Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Seattle Genetics Inc (SGEN)

Seattle Genetics Inc (SGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,022,700
  • Shares Outstanding, K 173,997
  • Annual Sales, $ 916,710 K
  • Annual Income, $ -158,650 K
  • 60-Month Beta 1.13
  • Price/Sales 36.51
  • Price/Cash Flow N/A
  • Price/Book 18.45
Trade SGEN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.66
  • Number of Estimates 7
  • High Estimate 3.57
  • Low Estimate -0.78
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
164.63 +1.32%
on 10/30/20
213.94 -22.03%
on 10/13/20
-28.89 (-14.76%)
since 09/30/20
3-Month
143.61 +16.15%
on 09/04/20
213.94 -22.03%
on 10/13/20
-4.34 (-2.54%)
since 07/30/20
52-Week
90.57 +84.17%
on 03/16/20
213.94 -22.03%
on 10/13/20
+62.20 (+59.46%)
since 10/30/19

Most Recent Stories

More News
Seagens (SGEN) Q3 Earnings Rise Y/Y, Adcetris Sales View Cut

Seagen's (SGEN) bottom line grows year over year in Q3 while revenues beat estimates. The company lowers the sales guidance for its lead product Adcetris.

RHHBY : 39.9900 (-0.52%)
MRK : 75.21 (-0.90%)
GSK : 33.42 (-1.59%)
SGEN : 166.80 (-13.28%)
Seattle Genetics (SGEN) Q3 Earnings and Revenues Top Estimates

Seattle Genetics (SGEN) delivered earnings and revenue surprises of 4475.00% and 166.81%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?...

SGEN : 166.80 (-13.28%)
Seattle Genetics: 3Q Earnings Snapshot

BOTHELL, Wash. (AP) _ Seattle Genetics Inc. (SGEN) on Thursday reported third-quarter net income of $636.2 million, after reporting a loss in the same period a year earlier.

SGEN : 166.80 (-13.28%)
Seagen Announces Closing of $1.0 Billion Stock Sale to Merck

Seagen Inc. (Nasdaq: SGEN) today announced the closing of a $1.0 billion equity investment by Merck in 5.0 million newly-issued shares of Seagen common stock at a price of $200 per share. The closing occurred...

MRK : 75.21 (-0.90%)
SGEN : 166.80 (-13.28%)
4 Innovative Biotech Stocks That Could Dominate Healthcare in 2021

Aging population, lifestyle changes and pandemics have created a huge demand for patient-focused healthcare. Biotech stocks like Seagen (SGEN), Genmab A/S (GMAB), Amedisys (AMED), and Masimo (MASI) could...

SGEN : 166.80 (-13.28%)
GMAB : 33.66 (-1.98%)
MASI : 223.82 (-0.82%)
AMED : 259.00 (+3.24%)
Merck (MRK) to Report Q3 Earnings: Is a Beat in the Cards?

Investor focus is likely to be on the sales numbers of Merck's (MRK) blockbuster oncology medicine, Keytruda.

AZN : 50.16 (-1.78%)
MRK : 75.21 (-0.90%)
GSK : 33.42 (-1.59%)
SGEN : 166.80 (-13.28%)
Seattle Genetics Set to Possibly Rebound After Yesterday's Selloff of 1.32%

Seattle Genetics (NASDAQ:SGEN) traded in a range yesterday that spanned from a low of $197.54 to a high of $201.86. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of...

SGEN : 166.80 (-13.28%)
5 Big Pharma/Biotech Stocks Set to Trump Q3 Earnings Estimates

Let us take a look at some drug/biotech stocks including Glaxo (GSK) and Merck (MRK) that are poised to beat on earnings for the third quarter.

MRK : 75.21 (-0.90%)
GSK : 33.42 (-1.59%)
BMY : 58.45 (+0.92%)
VRTX : 208.36 (+0.65%)
SGEN : 166.80 (-13.28%)
Seattle Genetics Up 25.1% Since SmarTrend Uptrend Call (SGEN)

SmarTrend identified an Uptrend for Seattle Genetics (NASDAQ:SGEN) on September 14th, 2020 at $163.78. In approximately 1 month, Seattle Genetics has returned 25.09% as of today's recent price of $204.87....

SGEN : 166.80 (-13.28%)
4 Top Biotech Stocks to Buy for the Remainder of 2020

With huge investments being made in biotech thanks to the pandemic, there has been a renewed focus on biotech stocks. Here are four worth considering: Amgen (AMGN), Immunomedics (IMMU), Seattle Genetics...

AMGN : 216.94 (-0.40%)
SGEN : 166.80 (-13.28%)
GMAB : 33.66 (-1.98%)
IMMU : 87.86 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Seagen Inc. is a biotechnology company. It discovers, develops and commercializes transformative cancer medicines. The company operates principally in California, Canada, Switzerland and the European Union. Seagen Inc., formerly known as Seattle Genetics Inc., is headquartered in the Seattle.

See More

Key Turning Points

2nd Resistance Point 185.85
1st Resistance Point 176.32
Last Price 166.80
1st Support Level 160.95
2nd Support Level 155.11

See More

52-Week High 213.94
Fibonacci 61.8% 166.81
Last Price 166.80
Fibonacci 50% 152.26
Fibonacci 38.2% 137.70
52-Week Low 90.57

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar